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Background/aim: Macrolide and lincosamide antibiotics are used for the treatment of staphylococcal infections, especially for
penicillin-allergic patients. In the present study, we evaluate the prevalence of resistance to macrolide and lincosamide antibiotics
among staphylococci isolates.
Materials and methods: A total of 200 staphylococcal clinical isolates were collected from January 2012 to April 2013. Minimal
inhibitory concentrations of erythromycin and clindamycin were determined by agar dilution method. An erythromycin-clindamycin
induction test was performed for isolates that were only resistant to erythromycin. Representative erythromycin-resistant isolates were
examined for erythromycin resistance genes using PCR.
Results: Among staphylococci isolates, resistance frequencies of erythromycin and clindamycin were 65.5% and 20.5%, respectively.
Erythromycin resistance was found to be mediated by putative efflux (50.4%) and target site modification (49.6%). Inducible target
site modification resistance was detected in 19.1% of erythromycin-resistant isolates. Among the examined 36 staphylococci isolates,
msr(A), erm(C), erm(A), and mef(A/E) genes were detected in 55.6%, 30.6%, 25%, and 0%, respectively.
Conclusion: Results of the current study indicate the presence of high rates of macrolide resistance and inducible phenotypes among
staphylococcal isolates. It is also essential to keep in mind variations of resistance rates among various age groups and specimen types.
Key words: Macrolides, lincosamide, erm, msr(A), resistance, staphylococci

1. Introduction
Staphylococcus aureus is responsible for several diseases,
such as toxic shock syndromes, bacteremia, skin infection,
folliculitis, and boils. Coagulase-negative staphylococci
(CONS) are an important cause of hospital-acquired
infections, particularly nosocomial bacteremia (1).
The expanded therapeutic application of macrolide
and lincosamide antibiotics has been accompanied
by increased numbers of resistant strains among
staphylococci (2,3). Two major mechanisms account for
resistance to macrolide, lincosamide, and streptogramin
B (MLSB) antibiotics in gram-positive bacteria (4). The
target site modification mechanism of resistance is
usually predominant. The mechanism depends on the
methylase enzyme (encoded by erm genes), which causes
ribosomal conformational changes rendering bacterial
strains resistant to most macrolides, lincosamides, and
streptogramin B compounds. Phenotypically, the pattern
is known as macrolide-lincosamide-streptogramin B
(MLS ) resistance and its expression can be constitutive or
B
inducible (4–7). In staphylococci, constitutive expression
of MLSB resistance can lead to cross-resistance to all
* Correspondence: motasemm@najah.edu
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macrolides, lincosamides, and streptogramin B (cMLSB)
(7). Strains with inducible resistance are resistant to
inducer macrolides (possess 14- and 15-membered rings).
By contrast, 16-membered ring macrolides, lincosamides
(e.g., clindamycin), and streptogramin B compounds that
are not inducers remain active. However, clindamycin
therapy for inducible phenotypes can lead to clinical
failure of treatment (7,8). The second mechanism is
mediated by an efflux pump. Staphylococci appear to have
a putative efflux system encoded by the msr(A) gene and
possess specificity for macrolide and type B streptogramin
molecules resulting in the MS-resistant phenotype (9,10).
The streptococci efflux pump is specific for macrolides
only and the resulting resistance pattern is referred to as
phenotype M. In streptococci, an active efflux pump is
encoded by mef(A) or mef(E) genes (11–13).
The aim of the current study was to determine the
prevalence and phenotypes of resistance to macrolides
and lincosamides among staphylococci clinical isolates
in the Nablus district. In addition, PCR for representative
isolates was carried out to detect macrolide resistance
genes reported to occur in staphylococci and streptococci.
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2. Materials and methods
2.1. Design and settings of the study
The current study was a prospective research study
conducted from January 2012 to April 2013 at An-Najah
National University. The population of the Nablus district
is approximately 364,000. Clinical isolates were collected
from two governmental hospitals, Rafedia (200 beds) and
Al-Watani (118 beds), and two private hospitals, Nablus
(80 beds) and Al-Arabi (60 beds). In addition, isolates
were also collected from two private medical laboratories
(New Technology and Medicare). The study protocol was
approved by the deans of An-Najah National University,
the Palestinian Ministry of Health, and the directors of the
participating clinical settings. All participating patients or
their parents accepted inclusion of their bacterial cultures
in the current study.
2.2. Bacterial isolates
Bacterial isolates were collected consecutively from
different clinical settings in the Nablus district. Patients’
clinical data were obtained from laboratory records.
Isolates were given identification numbers and stored in
20% glycerol nutrient broth at –70 °C. Hospital-associated
infections were defined as the occurrence of infection 48 h
after hospital admission.
2.3. Identification of bacterial isolates
The identification of bacterial isolates was confirmed by
several tests (1,14). Gram staining and catalase tests were
performed for all isolates. Identification of staphylococcal
bacteria was based on the coagulase test, mannitol salt
agar test, aerobic production of acid from maltose, urease
test, and susceptibility testing (bacitracin, novobiocin, and
polymyxin B). All chemicals were obtained from SigmaAldrich (USA) and the used antibiotic disks were obtained
from Oxoid (UK).
2.4. Determination of minimal inhibitory concentration
(MIC)
MICs were determined by agar dilution method.
Procedures including break points were carried out
according to the Clinical Laboratory Standards Institute
(CLSI) (1,15). Staphylococcus aureus ATCC 25923 was used
as a control strain with susceptibility to both erythromycin
and clindamycin antibiotics. Antibiotic powders were
obtained from Sigma-Aldrich.
2.5. Detection of inducible MLSB phenotype
Isolates resistant to erythromycin but susceptible to
clindamycin were examined by double disk diffusion
method (D-test) according to CLSI guidelines (16).
Antibiotic disks were obtained from Oxoid.
2.6. Detection of methicillin resistance
Resistance to oxacillin antibiotics was used to indicate
methicillin resistance among staphylococci isolates.
Susceptibility to oxacillin was detected by disk diffusion
method according to CLSI standards (15).

2.7. Detection of resistant genes
2.7.1. DNA extraction
Two to three bacterial colonies were suspended in a
Tris acetate-EDTA (TAE) buffer for 1 h. Samples were
then centrifuged at 1000 rpm for 5 min and pellets were
resuspended and boiled in distilled water for 15 min. DNA
was extracted by chloroform and DNA concentrations
were measured using a spectrophotometer. Extracted
DNA was stored at –20 °C until use.
2.7.2. Polymerase chain reaction (PCR)
The used primers and their sequences were erm(C):
5 ’ - G C TA ATAT TG T T TA A ATC G TC A AT TC C - 3 ’,
5’-GGATCAGGAAAAGGACATTTTAC-3’
(17);
erm(B):
5’-GAAAAGGTACTCAACCAAATA-3’,
5’-AGTAACGGTACTTAAATTGTTTAC-3’
(18);
erm(A):
5’-TCTAAAAAGCATGTAAAAGAA-3’,
5’-CTTCGATAGTTTATTAATATTAGT-3’
(2);
mef(A/E) primer (targets mef(A) and mef(E)
genes):
5’-AGTATCATTAATCACTAGTGC-3’,
5’-TTCTTCTGGTACTAAAAGTGG-3’
(18);
msr(A) primer (targets msr(A) and msr(B) genes):
5’GGCACAATAAGAGTGTTTAAAGG-3,
5’-AAGTTATATCATGAATAGATTGTCCTGTT-3’ (18).
PCR reagents were obtained from Sigma-Aldrich. The
reaction mixture was modified according to Sutcliffe et al.
(18). The PCR protocol was 5 min at 94 °C and 40 cycles
of 1 min at 94 °C for the denaturation, 90 s at 45 °C for
annealing, and 2 min at 72 °C for the extension step. The
cycles were followed by a final extension step at 72 °C for 7
min. PCR products were detected by 1.5% agarose gels and
stained with ethidium bromide.
2.8. Statistical analysis
Minitab 15.0 statistical analysis software was used. Chisquare or Fisher’s exact tests were applied to compare
the resistance frequencies among different groups.
Independent t-tests were used to compare mean values
among different age groups. For all analysis, P < 0.01 was
considered statistically significant.
3. Results
3.1. Bacterial isolates
A total of 200 staphylococcal isolates were collected during
the current study. The isolates comprised 187 S. aureus
and 13 CONS (12 S. epidermidis and 1 S. saprophyticus).
Isolates were recovered from different types of clinical
specimens and only one positive culture per patient was
included.
3.2. Resistance to antibiotics
Table 1 shows the resistance frequency among different
bacterial species. A total of 131 (65.5%) staphylococci
isolates were resistant to erythromycin. A much lower
frequency of resistance to clindamycin (20.5%) was found
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Table 1. Resistance to erythromycin and clindamycin in the studied bacterial isolates.
Erythromycin

Clindamycin

Bacteria species

No.*

Resistant
No. (%)

Intermediate
No. (%)

Susceptible
No. (%)

Resistant No.
(%)

Intermediate
No. (%)

Susceptible
No. (%)

Staphylococci

200

131 (65.5)

6 (3 )

63 (31.5)

41 (20.5)

6 (3)

153 (76.5)

S. aureus

187

121 (64.7)

6 (3.2)

60 (32.1)

39 (20.9)

5 (2.7)

143 (76.5)

CONS†

13

10 (76.9)

0 (0)

3 (23.1)

2 (15.4)

1 (7.7)

10 (76.9)

S. epidermidis

12

10 (83.3)

0 (0)

2 (16.7)

2 (16.7)

1 (8.3)

9 (75)

S. saprophyticus

1

0 (0)

0 (0)

1 (100)

0 (0)

0 (0)

1 (100)

*No., number; †CONS, coagulase-negative staphylococci.

among these isolates. The frequency of erythromycin
resistance among CONS was 76.9%, which was
insignificantly higher than that among S. aureus (64.7%).
Frequency of erythromycin resistance (70.6%)
among methicillin-resistant staphylococci isolates was
insignificantly (P = 0.095) higher than that among
methicillin- susceptible isolates (59.3%).
An erythromycin-clindamycin induction test
was performed for isolates that were resistant to
erythromycin but susceptible to clindamycin. MIC values
for erythromycin and clindamycin, the erythromycinclindamycin induction test, and detection of resistance
genes by PCR in representative isolates were combined
to predict the most probable mechanism of resistance.
Erythromycin resistance of staphylococci isolates
appeared to be mediated by a putative efflux mechanism
(MS phenotype, 50.4%) and target site modification
(MLSB phenotypes, 49.6%). Staphylococci isolates with
the target modification mode of resistance expressed the
MLSB phenotype constitutively and inducibly in 61.5%
and 38.5% of the isolates, respectively. Thus, a considerable
proportion of erythromycin-resistant isolates (19.1%)
exhibited inducible MLSB.

On the basis of resistance phenotypes and species of
bacteria, 36 erythromycin-resistant representative isolates
were examined for the presence of five resistance genes.
Distribution of resistance genes among the different
studied bacterial species and the predicted resistant
phenotypes are shown in Table 2. Among the representative
36 staphylococcal isolates analyzed by PCR, the msr(A)
gene was detected in 20 (55.6%), erm(C) in 11 (30.6%),
and erm(A) in 9 (25%). The mef gene was not detected in
any of the examined staphylococci isolates; however, it was
detected in Streptococcus agalactiae, which was used as a
positive control.
High percentages of erythromycin resistance were
found among staphylococci isolates obtained from
different clinical settings (Table 3). Staphylococci isolates
from the Al-Watani hospital showed the highest resistance
rates to erythromycin (85.7%) and clindamycin (85.7%).
These rates were significantly higher than those found
among isolates collected from the Rafedia hospital (P =
0.000).
With respect to erythromycin resistance, staphylococcal
strains isolated from the gynecology department had
the highest frequency (100%) compared to isolates from

Table 2. Macrolide resistance genes found in examined staphylococci isolates.
Type of bacteria and
resistance phenotype

Examined
isolates

Detected gene (%)
erm(A)*

erm(B)*

erm(C)*

msr(A)*

mef(A/E)*

Staphylococci

36

9 (25)

0 (0)

11 (30.6)

20 (55.6)

0 (0)

MLSB constitutive

7

0 (0)

0 (0)

7 (100)

1 (14.3)

0 (0)

MLSB inducible

11

8 (72.7)

0 (0)

4 (36.4)

1 (9.1)

0 (0)

MS

18

1 (5.55)

0 (0)

0 (0)

18 (100)

0 (0)

*erm, erythromycin ribosome methylase; msr, macrolide and streptogramin B resistant; mef, macrolide efflux; mef(A/E), mef(A), or/and
mef(E) gene(s) C, constitutive; I, inducible. CONS, coagulase-negative staphylococci.
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Table 3. Clinical data of erythromycin and/or clindamycin-resistant staphylococci isolates
Variable

No. of isolates*

E. R* (%)

DA. R* (%)

Source
Rafidia H*

140

90 (64.3)

22 (15.7)

New Technology Lab*

9

5 (55.6)

2 (22.2)

Nablus Specialty H*

21

12 (57.1)

6 (28.6)

Al-Arabi Specialty H*

18

14 (77.8)

3 (16.7)

Al-Watani H*

7

6 (85.7)

6 (85.7)

Medicare Lab*

5

4 (80)

2 (40)

Outpatients

56

41 (73.2)

14 (25)

Inpatients

144

90 (62.5)

27 (18.8)

General surgery

32

12 (37.5)

1 (3.1)

Emergency

17

9 (52.9)

0 (0)

Pediatrics

16

11 (68.8)

4 (25)

Burns

16

10 (62.5)

3 (18.8)

Neonates

14

12 (85.7)

5 (35.7)

Urology

14

8 (57.1)

3 (21.4)

ICU*

9

6 (66.7)

4 (44.4)

Internal medicine

13

10 (76.9)

4 (30.8)

Orthopedics

7

6 (85.7)

1 (14.3)

Gynecology

6

6 (100)

2 (33.3)

Wound swab

126

5 (59.5)

19 (15.1)

Urine

23

18 (78.3)

7 (30.4)

Blood

8

8 (100)

2 (25)

Sputum

6

4 (66.7)

4 (66.7)

Nasal swab

8

8 (100)

2 (25)

Various specimens (1–5)†

29

0-1 (0–100)

0–1 (0–100)

Male

113

78 (69.9)

26 (26.5)

Female

87

53 (60.9)

15 (18.4)

Total

200

31 (65.5)

41 (20.5)

Department

Specimen

Sex

Abbreviations: E. R, erythromycin-resistant; DA. R, clindamycin-resistant; H, hospital; Lab,
laboratory; ICU; intensive care unit.
† Specimens included those from skin, burn swab, tissue, chest swab, cerebrospinal fluid,
pus, drainage, breast discharge, fluid, throat swab, vaginal swab, umbilical swab, ear swab,
semen, or central venous catheter.

other departments, as well as outpatients’ isolates (Table
3). Frequency differences were significant in comparison
with those isolates obtained from outpatients and patients
of general surgery, emergency, pediatrics, and burns
departments (P = 0.000). On the other hand, the highest
frequency of clindamycin resistance was found in intensive

care units (44.4%), and it was also significantly higher than
that of emergency departments (P = 0.001).
With respect to specimen types from which the bacteria
were recovered, resistance to erythromycin was observed
in all staphylococci isolates obtained from blood and nasal
swabs (Table 3). This rate was significantly higher than
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that found among wound swabs (P = 0.000). Resistance to
clindamycin was highest in staphylococci bacteria isolated
from sputum (66.7%).
As shown in Table 4, staphylococci isolates’ resistance
to erythromycin was highest among age group 0–2 years
(74.5%) and age group >65 years (75%). In a similar
manner, clindamycin resistance among staphylococci was
highest in isolates collected from patients >65 years (50%),
and this was significantly higher than that among the age
group of 3–14 years (P = 0.007).
Evidence of nosocomial infection was found in 33 cases
(32 S. aureus and 1 S. epidermidis). Among the 33 cases,
22 (21 S. aureus and 1 S. epidermidis) were erythromycinresistant and 13 (12 S. aureus and 1 S. epidermidis) were
erythromycin- and clindamycin-resistant. Findings on
resistant phenotypes, antibiotic resistance profiles, and
sources of isolates for several samples (in one hospital:
pediatric, 2; urology, 2; and burns department, 3) indicated
the relatedness of isolates and their role in nosocomial
infections. To confirm this assumption, further molecular
typing of these isolates is required.
4. Discussion
In the current study, a high frequency of erythromycin
resistance among staphylococci isolates (65.5%) was
found. Resistance to erythromycin was more frequent in
CONS (76.9%) compared to that of S. aureus (64.7%).
A study from Turkey reported a high resistance rate
to erythromycin (59.2%) among staphylococci isolates
collected from 2003 to 2005 (19). That study also reported
a high resistance rate to erythromycin in CONS (69.8%)
compared to S. aureus isolates (49.6%). Such a finding is
in agreement with our results. This may be explained by
the frequent presence of CONS as normal flora in patients
before causing infection, a situation that allows longer
exposure periods to antibiotics and consequently better
conditions for natural selection of resistance.
In the present study, the erythromycin resistance rate
(70.6%) among methicillin-resistant staphylococci isolates
was insignificantly higher than that among methicillinsusceptible isolates (59.3%). The higher erythromycin
resistance rate among methicillin-resistant staphylococci
was linked to the presence of erythromycin-resistant genes
conserved in mec DNA (20).
The prevalence of clindamycin resistance among
staphylococci in our study (20.5%) was lower than that of
erythromycin (65.5%). This can be attributed mainly to
the frequent existence of the efflux mode of resistance (MS
phenotype) among staphylococci in our region, as well as
the induction capacity of erythromycin and not clindamycin
for methylase enzyme production among inducible MLSB
phenotypes. A higher rate of clindamycin resistance among
staphylococci (46.97%) was reported in India (21).
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Table 4. Distribution of erythromycin and clindamycin resistant
staphylococcal isolates among different age groups
Age group

Total

No.*

E. R* (%)

DA. R* (%)

0-2 years

55

51

38 (74.5)

13 (25.5)

3-14 years

32

29

15 (51.7)

1 (3.5)

15-39 years

56

36

22 (61.1)

3 (8.3)

40-65 years

41

31

18 (58.1)

8 (25.8)

>65 years

14

12

9 (75)

6 (50)

Unknown

54

41

29 (70.7)

10 (24.4)

* No., number; E. R, erythromycin-resistant; DA. R, clindamycinresistant.

In the current study, resistance of staphylococci to
erythromycin appeared to have been mediated by both
efflux (MS phenotype, 50.4%) and target site modification
(MLSB phenotypes, 49.6%) mechanisms. Both inducible
and constitutive MLSB phenotypes, as well as MS
phenotypes, were reported to occur, but with slightly
different frequencies (21). Among the erythromycinresistant staphylococcal isolates of the present study,
30.5% expressed the MLSB phenotype constitutively
and 19.1% inducibly. Thus, a considerable proportion of
erythromycin-resistant isolates exhibited an inducible
MLSB phenotype. These isolates will appear susceptible
to clindamycin in the disk diffusion method and will be
at a high risk of conversion from inducible to constitutive
MLSB phenotype in vivo. As a result of conversion, one
should expect clindamycin medication failure. Thus, the
erythromycin-clindamycin induction test is essential to
differentiate between strains carrying erm genes and fully
susceptible clindamycin strains (22).
Variations in erythromycin and clindamycin resistance
frequencies as well as resistant phenotypes in different
parts of the world are expected to occur due to time factors,
compliance with the use of antibiotics, the predominant
species among studied genera, and outbreaks of resistant
strains in different clinical settings.
In the current study, out of 36 examined staphylococci
isolates, 9 (25%) possessed erm(A), 11 (30.6%) erm(C),
and 20 (55.6%) msr(A). The erm(B) and mef(A/E) genes
were not detected. A low prevalence of erm(B) among
staphylococci was recorded in an earlier study (23). In
addition, the presence of mef gene appeared to be limited
to streptococci.
Variations in antibiotic resistance frequency among
different clinical settings seemed to be influenced by
hospital ward types. This was evident from the finding
of a higher percentage of erythromycin and clindamycin
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resistance among staphylococci isolates of Al-Watani
Hospital, which is specialized mainly for internal
medicine, where patients might be suffering from severe
infections, compared to Rafedia Hospital, which is mainly
a surgical hospital and admits patients most likely enrolled
for surgery. Furthermore, erythromycin resistance among
staphylococci isolates recovered from gynecology wards
was significantly higher than that of other wards. Most
of the women admitted to this ward were pregnant and/
or admitted for delivery. Such cases are more sensitive to
bacterial infection due to modulated immunity (24,25),
resulting in prolonged bacterial infection periods.
All staphylococci bacteria isolated from blood and
nasal swabs were resistant to erythromycin. Variations
in resistance rates were significant when compared with
wound swabs (P = 0.000). Many cases of bacteremia and
septicemia are complications after primary infection in
sites other than blood circulation (26). Usually a patient
receives treatment before these complications. Therefore,
the bacterial strains reaching the blood are expected to
be resistant to the antibiotics used for the treatment of
primary infections. The inside of the nasal cavity and the
respiratory tract are known for their poor blood circulation.
This is expected to decrease exposure of bacteria to the
immune system of the host and decrease the exposure
dose of antibiotics to bacteria. Under these conditions,
bacteria will have the opportunity to develop antibiotic
resistance. This might explain the high resistance rate to
erythromycin among staphylococci strains isolated from
nasal specimens. A high prevalence of multidrug resistance
(nonsusceptibility to ≥4 antimicrobial classes) in MRSA
nasal isolates was also reported by Davis et al. (27).

With respect to age groups, erythromycin resistance
showed the highest rate among staphylococci isolates
recovered from patients of 0–2 years and >65 years. In
addition, the clindamycin resistance rate among patients
of >65 years was significantly higher than in other groups.
This could be due to the capacity of the immune system
in these age groups. The current study shows clear
variations, one of which was statistically significant, in
resistance distribution among different age groups. Results
of previous studies support our findings. For example,
the findings of very high resistance rates to erythromycin
among staphylococci isolated from neonates (90% of S.
epidermidis and 100% of S. haemolyticus were resistant)
are in agreement with our findings regarding the age group
of 0–2 years (28). On the other hand, the findings of Adam
et al. (29) on resistance of S. aureus and other pathogens to
antibiotics (methicillin, clindamycin, and clarithromycin)
are consistent with our findings among the age group of
>65 years.
In conclusion, the results of the current study clearly
indicate the presence of high macrolide-resistance rates
among bacterial isolates collected from various clinical
settings. In addition, a considerable proportion of
macrolide resistance was due to inducible phenotypes,
and thus it seems essential to carry out the induction test
before any decision for clindamycin prescription. It is also
essential to keep in mind variations of resistance rates
among various age groups, specimen types, and pregnant
women in particular.
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